Mixed results for oral treprostinil formulation at Phase III

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF RESPIRATORY MEDICINE | 2011年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [41] Oral treprostinil use in children: a multicenter, observational experience
    Kanaan, Usama
    Varghese, Nidhy P.
    Coleman, Ryan D.
    Huckaby, Jeryl
    Lawrence, Patricia
    Jorgensen, Lynda O.
    Miller-Reed, Kathleen
    Day, Ronald W.
    Mallory, George B.
    Ivy, David D.
    PULMONARY CIRCULATION, 2019, 9 (03)
  • [42] First Reported Clinical Use of Oral Treprostinil QID
    Simon, Marc
    Bunner, Cheryl
    Coons, James
    Ishizawar, David
    CHEST, 2015, 148 (04)
  • [43] Efficacy of oral treprostinil as an add-on therapy for PAH
    Kiely, D.
    Gruenig, E.
    Balasubramanian, V
    Barbera, J.
    Vizza, C. D.
    Elwing, J.
    Sood, N.
    Rao, Y.
    Holdstock, L.
    Seaman, S.
    Broderick, M.
    White, R. J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [44] Inpatient Initiation of Oral Treprostinil in an Academic Medical System
    Benjamin Hohlfelder
    Adriano R. Tonelli
    Gustavo A. Heresi
    Nancy Bair
    Franck F. Rahaghi
    Seth R. Bauer
    Cardiovascular Drugs and Therapy, 2020, 34 : 547 - 553
  • [45] Prolonged Pharmacokinetic Profile Of A Prodrug Lipid Nanoparticle Formulation Of Treprostinil In Dogs
    Leifer, F. G.
    Konicek, D.
    Li, Z.
    Malinin, V.
    Damiano, J.
    Magid, Y.
    Cracknell, S.
    Curran, A.
    Perkins, W.
    Chapman, R. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [46] Pharmacokinetic And Safety Profile Of Treprostinil Following Three-Times Daily Dosing Of Oral Treprostinil In Healthy Subjects
    Jenkins, A.
    Wang-Smith, L.
    Pham, T.
    Laliberte, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [47] LONG-TERM CLINICAL OUTCOMES IN A SERIES OF PATIENTS TRANSITIONED FROM INFUSED OR INHALED TREPROSTINIL TO ORAL TREPROSTINIL
    Swisher, John
    Weaver, Eric
    Overton-Barnes, Regina
    CHEST, 2018, 154 (04) : 1042A - 1042A
  • [48] Oral delivery of anticancer drugs III: formulation using drug delivery systems
    Mazzaferro, Silvia
    Bouchemal, Kawthar
    Ponchel, Gilles
    DRUG DISCOVERY TODAY, 2013, 18 (1-2) : 99 - 104
  • [49] Disappointing results for phase III semagacestat trial
    Reactions Weekly, 2013, 1473 (1) : 2 - 2
  • [50] Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results
    Pengo, V.
    Crippa, L.
    Falanga, A.
    Finazzi, G.
    Marongiu, F.
    Moia, M.
    Palareti, G.
    Poli, D.
    Testa, S.
    Tiraferri, E.
    Tosetto, A.
    Tripodi, A.
    Siragusa, S.
    Manotti, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (10) : 1979 - 1987
12345